Memory-enhancing drug may improve exposure therapy for PTSD patients

November 3, 2011 in Psychology & Psychiatry

A memory-enhancing drug may improve the speed and effectiveness of prolonged exposure therapy for post-traumatic stress disorder (PTSD) patients, according to a new pilot study by psychologists at The University of Texas at Austin, the University of Washington and the University of Pennsylvania.

To lessen the time it takes for PTSD patients to recover, University of Texas at Austin psychology professors Michael Telch and Francisco Gonzalez-Lima, along with their team of researchers, are pairing prolonged exposure therapy with United States Pharmacopeia (USP) methylene blue.

In prolonged exposure therapy, patients repeatedly recount a fearful event. As the patients begin to look at the memory differently, the memory has less control over their lives.

The researchers believe the FDA-approved compound methylene blue, which significantly improved fear extinction in rats in an earlier study conducted in the Gonzalez-Lima Lab, will help strengthen memory that occurred during therapy sessions with PTSD patients. Normally, about two-thirds of PTSD patients treated with prolonged during ten 90-minute sessions no longer exhibit PTSD.

As part of the study, respondents take a placebo pill or a dose of USP methylene blue after a therapy session. The researchers theorize the drug will help patients recover faster and better in only six daily one-hour sessions.

Post-traumatic stress symptoms often emerge immediately after , such as combat experience, abuse, rape, robbery, accidents and . For most, these symptoms subside on their own soon after the trauma. However, about 30 percent of trauma victims go on to develop PTSD in which their trauma memories continue to haunt them and create significant distress and life impairment for months or years after the event.

Because prolonged, repeated recall of during behavior therapy stimulates new adaptive learning around the memories, the researchers predict that patients given a memory boost with USP methylene blue immediately after therapy sessions will make more lasting gains during therapy than those who do not take the medication.

Taken orally, the chemical properties of USP methylene blue affect regions of the brain, such as those stimulated after thinking about a memory.

“Methylene blue easily crosses the blood-brain barrier and accumulates inside activated brain cells,” Gonzalez-Lima says. “Once inside the neurons, the substance zooms in on mitochondria – the power house of the cell – to keep it active and enable the brain cells to keep processing the memory.”

Provided by University of Texas at Austin search and more info website

4 /5 (1 vote)  

Rank 4 /5 (1 vote)
Relevant PhysicsForums posts

More news stories

Study reviews readmissions in inpatient psychiatric facilities

(HealthDay)—Most Medicare beneficiaries treated in inpatient psychiatric facilities (IPFs) exhibit characteristics associated with hospital readmission, according to a report prepared for the National Association ...

Psychology & Psychiatry created 18 hours ago | popularity not rated yet | comments 0

Skydiving is never plane sailing

Skydivers show the same level of physical stress before every jump whether a first-timer or experienced jumper, say Northumbria researchers.

Psychology & Psychiatry created 19 hours ago | popularity not rated yet | comments 0 | with audio podcast

Kids, especially boys, perceive sadness of depressed parents

Children of depressed parents pick up on their parents' sadness—whether mom or dad realizes their mood or not.

Psychology & Psychiatry created May 17, 2013 | popularity 4.5 / 5 (2) | comments 1 | with audio podcast

One in five U.S. kids has a mental health disorder, CDC reports

(HealthDay)—As many as one in five American children under the age of 17 has a diagnosable mental disorder in a given year, according to a new federal report.

Psychology & Psychiatry created May 16, 2013 | popularity 2 / 5 (4) | comments 1 | with audio podcast

Bach to the blues, our emotions match music to colors

(Medical Xpress)—Whether we're listening to Bach or the blues, our brains are wired to make music-color connections depending on how the melodies make us feel, according to new research from the University ...

Psychology & Psychiatry created May 16, 2013 | popularity not rated yet | comments 0 | with audio podcast


AIDS science at 30: 'Cure' now part of lexicon

Big names in medicine are set to give an upbeat assessment of the war on AIDS on Tuesday, 30 years after French researchers identified the virus that causes the disease.

For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...

Melon focus headband turns to Kickstarter for rollout plans

(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...

Temporal processing in the olfactory system

The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...

Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria

In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as ...

23 dead in initiation rites in South Africa

(AP)—Twenty-three youths have died in the past nine days at initiation ceremonies that include circumcisions and survival tests, South African police said Friday.